|
Delayed
Nasdaq
17:48:27 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.470 USD | +4.26% |
|
+4.26% | +12.21% |
| 10-12 | MediciNova Phase 2 Trial in Fatty Liver Disease Drug Misses Primary Endpoints | MT |
| 10-12 | Medicinova, Inc. Provides Update on Mn-001 Phase 2 Clinical Trial Results and Mn-166 Combat-Als Trial | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.26% | +4.26% | -30.00% | +10.53% | +12.21% | +21.49% | -25.00% | -58.00% | -79.21% | 69.4M | |
| +0.65% | -3.56% | -12.32% | +14.23% | +57.11% | +33.53% | +60.50% | +5.04% | - | 63.48B | |
| +2.27% | +1.81% | -5.19% | +3.73% | +11.72% | +12.41% | +83.08% | +232.83% | +5,492.18% | 54.55B | |
| -0.83% | +0.83% | +7.63% | +12.25% | +16.92% | +10.28% | +101.86% | -17.13% | +233.58% | 53.59B | |
| +3.01% | +2.02% | +4.15% | +16.17% | +25.20% | +29.38% | +59.30% | +9.73% | +293.23% | 44.75B | |
| +2.46% | -3.03% | +2.11% | +13.40% | +23.35% | +18.27% | +100.82% | +2.79% | +1,019.67% | 41.62B | |
| +0.70% | -3.43% | -7.00% | +2.05% | +135.56% | +222.55% | +922.48% | +530.67% | - | 39.91B | |
| +0.64% | -3.85% | +6.99% | +6.21% | +10.10% | +11.71% | +45.57% | +5.41% | +152.66% | 32.47B | |
| +26.94% | +42.44% | +62.12% | +95.60% | +84.11% | +99.84% | +87.44% | +31.45% | +230.27% | 26.7B | |
| +3.72% | -6.23% | -13.26% | +20.06% | +47.33% | +26.01% | -8.28% | -59.79% | - | 23.36B | |
| +0.43% | -4.04% | -11.58% | -5.24% | -7.98% | -16.59% | -6.05% | -69.15% | - | 21.87B | |
| +1.18% | +1.71% | -18.72% | -8.15% | -45.04% | -42.14% | +301.87% | +223.23% | +606.39% | 20.74B | |
| +1.56% | +3.75% | +11.59% | +20.38% | +22.37% | +18.39% | +184.25% | +212.83% | +2,279.06% | 18.85B | |
| +4.04% | +9.17% | +27.80% | +56.59% | +88.74% | +100.34% | +128.84% | -14.20% | +395.39% | 17.13B | |
| +0.98% | +6.70% | +9.65% | +25.98% | +38.33% | +41.51% | +84.72% | -16.11% | +110.41% | 16.53B | |
| +1.09% | +2.28% | +13.16% | +16.88% | +50.70% | +64.82% | +226.33% | +203.54% | +507.08% | 16.19B | |
| +0.63% | +3.57% | +7.55% | -2.76% | - | - | - | - | - | 16.15B | |
| +0.84% | +3.90% | +3.90% | +0.42% | +183.22% | +163.59% | +345.61% | +1,418.19% | +787.21% | 15.21B | |
| -4.32% | -8.37% | -4.75% | -14.73% | +10.56% | +2.80% | +430.07% | - | - | 13.81B | |
| +11.30% | +9.89% | +15.95% | +12.95% | +11.72% | +14.54% | -14.51% | -28.93% | +153.46% | 14.12B | |
| Average | +3.05% | +1.85% | +3.49% | +14.83% | +40.85% | +43.83% | +163.63% | +145.13% | +870.10% | 27.55B | |
| Weighted average by Cap. | +2.73% | +0.90% | +3.05% | +14.63% | +40.65% | +43.49% | +166.34% | +123.81% | +1,248.90% |
- Stock Market
- Stocks
- MNOV Stock
- Sector MediciNova, Inc.
Select your edition
All financial news and data tailored to specific country editions
